Variant report
Variant | nsv437519 |
---|---|
Chromosome Location | chr6:101932126-101951502 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145022984 | chr6:101933014-101933015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575104654 | chr6:101933016-101933017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs367576458 | chr6:101933027-101933028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs989467 | chr6:101933087-101933088 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs535111649 | chr6:101933150-101933151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138791326 | chr6:101933189-101933190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565681939 | chr6:101933190-101933191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs371939826 | chr6:101933210-101933211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539514051 | chr6:101933241-101933242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557567627 | chr6:101933242-101933243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191841442 | chr6:101933277-101933278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184453723 | chr6:101933346-101933347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142045266 | chr6:101933378-101933379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541862650 | chr6:101933488-101933489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554133572 | chr6:101933504-101933505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374767244 | chr6:101933524-101933525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs989466 | chr6:101933529-101933530 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs189279979 | chr6:101933543-101933544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531956628 | chr6:101933571-101933572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543989850 | chr6:101933598-101933599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562245479 | chr6:101933652-101933653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs78668037 | chr6:101933751-101933752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547115051 | chr6:101933787-101933788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs67073947 | chr6:101933792-101933793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565656697 | chr6:101933820-101933821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532893948 | chr6:101933856-101933857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187044497 | chr6:101933873-101933874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72610841 | chr6:101933888-101933889 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs189551782 | chr6:101933896-101933897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555491428 | chr6:101933904-101933905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181447493 | chr6:101933980-101933981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186132570 | chr6:101934058-101934059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs553906958 | chr6:101934059-101934060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572426027 | chr6:101934165-101934166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549164515 | chr6:101934166-101934167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs78314093 | chr6:101934214-101934215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12194713 | chr6:101934215-101934216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12110583 | chr6:101934239-101934240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544073079 | chr6:101934260-101934261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73504614 | chr6:101934267-101934268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149381188 | chr6:101934268-101934269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529596352 | chr6:101934271-101934272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201494825 | chr6:101934272-101934273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs66744316 | chr6:101934276-101934277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541692251 | chr6:101934278-101934279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559769807 | chr6:101934280-101934281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532782508 | chr6:101934283-101934284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs112338276 | chr6:101934306-101934307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs569416137 | chr6:101934349-101934350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530518470 | chr6:101934396-101934397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21785460 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Obesity | 21045960 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Autism | 22543975 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:101933000-101934600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr6:101933200-101934600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr6:101933400-101934600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr6:101933400-101934800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr6:101933800-101934200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr6:101933800-101934600 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr6:101933800-101934600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr6:101933800-101934600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr6:101934000-101934600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr6:101934000-101935000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr6:101950600-101951200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr6:101950600-101951200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr6:101950800-101951200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr6:101951200-101951600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |